These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
79 related articles for article (PubMed ID: 3560720)
1. [Hemoperfusion through a mixture of living donor hepatocytes in the treatment of severe hepatic failure]. Margulis MS; Erukhimov EA; Andreĭman LA; Kuznetsov KA; Viksna LM Khirurgiia (Mosk); 1987 Feb; (2):107-10. PubMed ID: 3560720 [No Abstract] [Full Text] [Related]
2. [Treatment of hepatic failure using hemoperfusion through a suspension of live isolated hepatocytes]. Margulis MS; Erukhimov EA; Andreĭman LA Anesteziol Reanimatol; 1986; (3):29-31. PubMed ID: 3752601 [No Abstract] [Full Text] [Related]
3. [Experience in using hemosorption in treating liver failure]. Skiba VV; Voĭtenko GH; Kolesnikov EB; Zubkov VI; Bondarevskaia TM Klin Med (Mosk); 1980 Apr; 58(4):87-90. PubMed ID: 7382374 [No Abstract] [Full Text] [Related]
4. [Effect of hemosorption on blood insulin levels in patients with chronic liver failure]. Sitnikov VA; Pozdeev SR; Bryndin VV; Zelenin AA Vrach Delo; 1983 Aug; (8):91-4. PubMed ID: 6356596 [No Abstract] [Full Text] [Related]
5. Prolonged hemoperfusion and hemodialysis in management of hepatic failure and hepatorenal syndrome. Krumlovsky FA; del Greco F; Niederman M Trans Am Soc Artif Intern Organs; 1978; 24():235-8. PubMed ID: 716004 [No Abstract] [Full Text] [Related]
6. [Treatment of acute pancreatitis patients with functional liver failure]. Koval'chuk VI; Sapov IA; Kuleshov VI; Lapshin VN; Salamatin BN Vestn Khir Im I I Grek; 1984 Sep; 133(9):26-30. PubMed ID: 6495547 [TBL] [Abstract][Full Text] [Related]
7. Influence of hemoperfusion using coated bead-type charcoal on middle molecules of hepatic failure dogs. Nishiki M; Kawanishi H; Kanao M; Sugiyama M; Tsuchiya T; Ezaki H Hiroshima J Med Sci; 1984 Sep; 33(3):493-7. PubMed ID: 6511475 [No Abstract] [Full Text] [Related]
8. [Effect of hemosorption on the clinical course of chronic liver diseases]. Kurdybaĭlo FV; Kolmakov VN; Nechaev IV; Potapova IV; Radchenko VG Vrach Delo; 1988 Jul; (7):60-3. PubMed ID: 3188472 [No Abstract] [Full Text] [Related]
9. [Hemoperfusion across charcoal in acute hepatic failure in the dog]. Horák J; Horký J; Rábl M Cesk Gastroenterol Vyz; 1980 Mar; 34(2):86-95. PubMed ID: 7388982 [No Abstract] [Full Text] [Related]
10. [Differential approach to hemodialysis, hemosorption and isolated ultrafiltration in acute kidney-liver failure]. Bukin VE; Shifrin GA; Oleĭnik PP; Stupakov VI; Taslitskiĭ LI Anesteziol Reanimatol; 1985; (2):68-70. PubMed ID: 4003845 [No Abstract] [Full Text] [Related]
11. [Effect of hemosorption on the blood levels of certain hormones in patients with pancreonecrosis and the hepatorenal syndrome]. Riabov GA; Pospelov VV; Semenov VN; Bunin VM; Emtsov IuG Anesteziol Reanimatol; 1982; (3):35-7. PubMed ID: 7114564 [No Abstract] [Full Text] [Related]
12. [The enhancement of treatment efficacy in chronic liver failure by using hemoperfusion across donor hepatocytes and spleen fragments]. Onishchenko NA; Bazieva FKh; Orzhekhovskaia IG; Toshchakov VIu; Polosina OV; Danilov MA; Suskova VS Ter Arkh; 1995; 67(2):6-9. PubMed ID: 7725264 [TBL] [Abstract][Full Text] [Related]
13. [Use of hemosorption in the treatment of patients with chronic liver diseases]. Radchenko VG; Litvinov AS; Vinogradova GL Ter Arkh; 1987; 59(2):118-21. PubMed ID: 3576464 [TBL] [Abstract][Full Text] [Related]
14. [Direct hemoperfusion combined with other blood purification]. Negi S; Abe T Nihon Rinsho; 1991 Dec; 49 Suppl():644-8. PubMed ID: 1808330 [No Abstract] [Full Text] [Related]
15. [Ion-exchange hemosorption in the intensive therapy of liver insufficiency in patients with obstructive jaundice]. Minina KZ; Kurapov EP; Goncharov VV; Leĭkin IuA; Tarasova TI; Treushnikova NIu Anesteziol Reanimatol; 1989; (4):40-2. PubMed ID: 2817498 [TBL] [Abstract][Full Text] [Related]
16. [Blood purification, plasma exchange and molecular adsorbents recycling system recur the amanita phalloides mushroom poisoning patients with severe hepatic damage]. Wu BF; Yang JY; Jiang CQ; Huang RH; Liu WW Zhonghua Gan Zang Bing Za Zhi; 2003 Aug; 11(8):507. PubMed ID: 12939195 [No Abstract] [Full Text] [Related]
17. [Preliminary evaluation on the effects of a hybrid bioartificial liver support system in the treatment of hepatic failure]. Wang YJ; He NH; Niu RZ; Liu J; Wen HW; Li JJ; Wang YM Zhonghua Gan Zang Bing Za Zhi; 2003 Aug; 11(8):461-3. PubMed ID: 12939175 [TBL] [Abstract][Full Text] [Related]
18. [Complex treatment of hepatic insufficiency by hemosorption]. Voitenko GN; Shalimov SA; Skiba VV; Zemskov VS Vrach Delo; 1981 Jan; (1):13-5. PubMed ID: 7210622 [No Abstract] [Full Text] [Related]
19. [Use of a hepatocyte suspension in a hemosorption system in acute hepatic failure (experimental study)]. Margulis MS; Erukhimov EA; Andreĭman LA; Kuznetsov KA; Sorokin IuA Khirurgiia (Mosk); 1985 Feb; (2):121-4. PubMed ID: 3981921 [No Abstract] [Full Text] [Related]
20. Nutritional implications of artificial liver support systems in fulminant hepatic failure. Denis J; Opolon P; N'Guyen-Dinh F; Raisonnier A; Levy VG Acta Chir Scand Suppl; 1981; 507():69-80. PubMed ID: 7032174 [No Abstract] [Full Text] [Related] [Next] [New Search]